Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 9:01 PM View:  | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Adma Biologics, Inc. (ADMA) | 01-Apr-24 | Grant | 192,320 | -- | -- | 171% 112.19K to 304.51K | |
| 02-Apr-24 9:01 PM View: | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Adma Biologics, Inc. (ADMA) | 31-Mar-24 | Payment of Exercise | 2,085 | $6.60 | $13,761.00 | (2%) 114.28K to 112.19K | |
| 02-Apr-24 9:00 PM View: | Grossman Adam S President,CEO, and Interim CFO Director | Adma Biologics, Inc. (ADMA) | 31-Mar-24 | Payment of Exercise | 21,752 | $6.60 | $143,563.00 | (< 1%) 4.4M to 4.38M | |
| 19-Mar-24 9:48 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 19-Mar-24 | Sale | 411,829 | $6.08 | $2,503,920.00 | (16%) 2.6M to 2.19M | |
| 19-Mar-24 9:48 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 18-Mar-24 | Private Sale | 49,887 | $6.01 | $299,821.00 | (2%) 2.65M to 2.6M | |
| 15-Mar-24 9:00 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 15-Mar-24 | Sale | 183,008 | $6.01 | $1,099,880.00 | (6%) 2.84M to 2.65M | |
| 15-Mar-24 9:00 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 14-Mar-24 | Sale | 448,276 | $6.05 | $2,712,070.00 | (14%) 3.29M to 2.84M | |
| 15-Mar-24 9:00 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 13-Mar-24 | Private Sale | 407,000 | $6.21 | $2,527,470.00 | (11%) 3.69M to 3.29M | |
| 08-Mar-24 9:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 07-Mar-24 | Payment of Exercise | 28,763 | $6.16 | $177,180.00 | (< 1%) 4.43M to 4.4M | |
| 08-Mar-24 9:01 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 07-Mar-24 | Payment of Exercise | 16,965 | $6.16 | $104,504.00 | (2%) 719.97K to 703.0K | |
| 08-Mar-24 9:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 06-Mar-24 | Payment of Exercise | 55,003 | $6.12 | $336,618.00 | (1%) 4.48M to 4.43M | |
| 08-Mar-24 9:01 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 06-Mar-24 | Payment of Exercise | 16,677 | $6.12 | $102,063.00 | (2%) 736.64K to 719.97K | |
| 04-Mar-24 9:00 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 29-Feb-24 | Payment of Exercise | 4,935 | $5.36 | $26,451.60 | (< 1%) 741.58K to 736.64K | |
| 04-Mar-24 9:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 29-Feb-24 | Payment of Exercise | 9,588 | $5.36 | $51,391.70 | (< 1%) 4.49M to 4.48M | |
| 28-Feb-24 9:00 PM View: | Guiheen Lawrence P. Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | 18% 130.9K to 154.94K | |
| 28-Feb-24 9:00 PM View: | Finger Alison Cecily Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | 100% 0 to 24.04K | |
| 28-Feb-24 9:00 PM View: | Fong Bryant Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | 40% 59.9K to 83.94K | |
| 28-Feb-24 9:00 PM View: | Grossman Jerrold B Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | 4% 535.97K to 560.01K | |
| 28-Feb-24 9:00 PM View: | Kwon Young Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | 9% 277.4K to 301.44K | |
| 28-Feb-24 9:00 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | < 1% 3.67M to 3.69M | |
| 28-Feb-24 9:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 557,728 | -- | -- | 14% 3.93M to 4.49M | |
| 27-Feb-24 9:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 25-Feb-24 | Payment of Exercise | 22,457 | $5.26 | $118,124.00 | (< 1%) 3.96M to 3.93M | |
| 27-Feb-24 9:03 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 25-Feb-24 | Payment of Exercise | 8,257 | $5.26 | $43,431.80 | (1%) 749.84K to 741.58K | |
| 05-Jan-24 9:00 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 31-Dec-23 | Payment of Exercise | 16,908 | $4.52 | $76,424.20 | (2%) 766.74K to 749.84K | |
| 05-Jan-24 9:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 31-Dec-23 | Payment of Exercise | 23,057 | $4.52 | $104,218.00 | (< 1%) 3.98M to 3.96M | |
| 03-Oct-23 10:00 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 30-Sep-23 | Payment of Exercise | 15,268 | $3.58 | $54,659.40 | (2%) 782.01K to 766.74K | |
| 03-Oct-23 10:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 30-Sep-23 | Payment of Exercise | 18,718 | $3.58 | $67,010.40 | (< 1%) 4.0M to 3.98M | |
| 30-Aug-23 4:58 PM View: | Grossman Jerrold B Director | Adma Biologics, Inc. (ADMA) | 30-Aug-23 | Purchase | 130,000 | $3.71 | $482,144.00 | 32% 405.97K to 535.97K | |
| 24-Aug-23 7:53 PM View: | Kwon Young Director | Adma Biologics, Inc. (ADMA) | 24-Aug-23 | Purchase | 25,000 | $3.90 | $97,500.00 | 10% 252.4K to 277.4K | |
| 23-Aug-23 8:30 PM View: | Fong Bryant Director | Adma Biologics, Inc. (ADMA) | 22-Aug-23 | Private Sale | 1,433,300 | $3.87 | $5,544,740.00 | (96%) 1.49M to 59.9K | |
| 18-Aug-23 9:46 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 18-Aug-23 | Private Sale | 250,000 | $4.15 | $1,038,350.00 | (6%) 4.25M to 4.0M | |
| 17-Aug-23 9:30 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 16-Aug-23 | Option Sale | 178,184 | $4.45 | $793,400.00 | (19%) 960.2K to 782.01K | |
| 17-Aug-23 9:30 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 16-Aug-23 | Option Sale | 3 | $4.39 | $13.15 | (< 1%) 4.25M to 4.25M | |
| 17-Aug-23 9:30 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 15-Aug-23 | Option Exercise | 2,100,460 | $3.11 | $6,536,450.00 | 49% 4.25M to 6.35M | |
| 17-Aug-23 9:30 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 15-Aug-23 | Option Exercise | 809,262 | $3.11 | $2,514,360.00 | 81% 993.59K to 1.8M | |
| 17-Aug-23 9:30 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 15-Aug-23 | Payment of Exercise | 1,589,990 | $4.61 | $7,329,840.00 | (25%) 6.35M to 4.76M | |
| 17-Aug-23 9:30 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 15-Aug-23 | Option Sale | 510,469 | $4.54 | $2,318,960.00 | (11%) 4.76M to 4.25M | |
| 17-Aug-23 9:30 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 15-Aug-23 | Payment of Exercise | 631,078 | $4.61 | $2,909,270.00 | (35%) 1.8M to 1.17M | |
| 17-Aug-23 9:30 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 15-Aug-23 | Option Sale | 211,578 | $4.60 | $972,730.00 | (18%) 1.17M to 960.2K | |
| 05-Jul-23 10:00 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 30-Jun-23 | Payment of Exercise | 20,051 | $3.69 | $73,988.20 | (< 1%) 4.27M to 4.25M | |
| 05-Jul-23 10:00 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 30-Jun-23 | Payment of Exercise | 15,268 | $3.69 | $56,338.90 | (2%) 1.01M to 993.59K | |
| 04-Apr-23 9:06 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 31-Mar-23 | Payment of Exercise | 17,853 | $3.31 | $59,093.40 | (< 1%) 4.29M to 4.27M | |
| 04-Apr-23 9:08 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 31-Mar-23 | Payment of Exercise | 15,469 | $3.31 | $51,202.40 | (2%) 1.02M to 1.01M | |
| 08-Mar-23 9:30 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 07-Mar-23 | Payment of Exercise | 16,965 | $3.40 | $57,681.00 | (2%) 1.04M to 1.02M | |
| 08-Mar-23 9:30 PM View: | Grossman Adam S President and CEO Director | Adma Biologics, Inc. (ADMA) | 07-Mar-23 | Payment of Exercise | 23,607 | $3.40 | $80,263.80 | (< 1%) 4.31M to 4.29M | |
| 08-Mar-23 9:30 PM View: | Demski Martha J Director | Adma Biologics, Inc. (ADMA) | 06-Mar-23 | Grant Duplicate | 25,815 | -- | -- | 84% 30.79K to 56.6K | |
| 08-Mar-23 9:30 PM View: | Kwon Young Director | Adma Biologics, Inc. (ADMA) | 06-Mar-23 | Grant | 25,815 | -- | -- | 11% 226.59K to 252.4K | |
| 08-Mar-23 9:30 PM View: | Lenz Brian EVP, CFO | Adma Biologics, Inc. (ADMA) | 06-Mar-23 | Grant | 135,175 | -- | -- | 15% 906.12K to 1.04M | |
| 08-Mar-23 9:30 PM View: | Fong Bryant Director | Adma Biologics, Inc. (ADMA) | 06-Mar-23 | Grant | 25,815 | -- | -- | 2% 1.47M to 1.49M | |
| 08-Mar-23 9:30 PM View: | Elms Steve Director | Adma Biologics, Inc. (ADMA) | 06-Mar-23 | Grant | 25,815 | -- | -- | < 1% 3.64M to 3.67M |
